| scholarly article | Q13442814 |
| P50 | author | Paul Spellman | Q59752875 |
| Joe W. Gray | Q85648340 | ||
| Kelsey T Morgan | Q85857834 | ||
| P2093 | author name string | Andrei Purmal | |
| Daria Fleyshman | |||
| Mairead Commane | |||
| Alfiya Safina | |||
| Katerina Gurova | |||
| Nicholas J Wang | |||
| Natalia Issaeva | |||
| Anda Ströse | |||
| Shaila Mudambi | |||
| Peter Cheney | |||
| P2860 | cites work | AU binding proteins recruit the exosome to degrade ARE-containing mRNAs | Q24291926 |
| Ribonuclease activity and RNA binding of recombinant human Dicer | Q24315047 | ||
| Human checkpoint protein hRad9 functions as a negative coregulator to repress androgen receptor transactivation in prostate cancer cells | Q24607572 | ||
| Small molecule screening reveals a transcription-independent pro-survival function of androgen receptor in castration-resistant prostate cancer | Q24620356 | ||
| Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells | Q24675586 | ||
| Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation | Q24793292 | ||
| The convergence of DNA damage checkpoint pathways and androgen receptor signaling in prostate cancer | Q27014101 | ||
| A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 | Q28115843 | ||
| p53 and breast cancer, an update | Q28242379 | ||
| Replication protein A: a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism | Q28245231 | ||
| The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer | Q28251975 | ||
| Linkage of early-onset familial breast cancer to chromosome 17q21 | Q28268902 | ||
| p21-Activated kinase 6 (PAK6) inhibits prostate cancer growth via phosphorylation of androgen receptor and tumorigenic E3 ligase murine double minute-2 (Mdm2) | Q28278797 | ||
| Hereditary and familial colon cancer | Q28280647 | ||
| Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of Assays | Q28546583 | ||
| Double-check probing of DNA bending and unwinding by XPA-RPA: an architectural function in DNA repair | Q30684974 | ||
| Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor. | Q33925761 | ||
| Novel binding of HuR and poly(C)-binding protein to a conserved UC-rich motif within the 3'-untranslated region of the androgen receptor messenger RNA. | Q34128437 | ||
| miR 488* inhibits androgen receptor expression in prostate carcinoma cells | Q34196086 | ||
| Phenotypic screening in cancer drug discovery - past, present and future | Q34429484 | ||
| DNA repair mechanisms in dividing and non-dividing cells | Q34727858 | ||
| BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription. | Q35163327 | ||
| Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cells | Q35184378 | ||
| XRCC1 and DNA strand break repair | Q35216366 | ||
| Replication stress-induced chromosome breakage is correlated with replication fork progression and is preceded by single-stranded DNA formation | Q35746771 | ||
| Subtype and pathway specific responses to anticancer compounds in breast cancer | Q35779241 | ||
| The androgen receptor mRNA. | Q35788444 | ||
| The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells | Q35842164 | ||
| Phenotypic screens as a renewed approach for drug discovery | Q35936197 | ||
| Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains | Q36820883 | ||
| Why does androgen deprivation enhance the results of radiation therapy? | Q37261956 | ||
| miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer | Q37375623 | ||
| Androgen receptor and caveolin-1 in prostate cancer. | Q37605027 | ||
| ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions | Q37805529 | ||
| Complexities of androgen receptor signalling in breast cancer. | Q38222027 | ||
| A targetable androgen receptor-positive breast cancer subtype hidden among the triple-negative cancers | Q38259605 | ||
| Androgen receptor signaling regulates DNA repair in prostate cancers | Q39096880 | ||
| Curaxins: anticancer compounds that simultaneously suppress NF-κB and activate p53 by targeting FACT. | Q39492096 | ||
| Small molecule metabolite extraction strategy for improving LC/MS detection of cancer cell metabolome. | Q39566899 | ||
| Expression of androgen receptor is negatively regulated by p53. | Q40034771 | ||
| Prostate cancer cells tolerate a narrow range of androgen receptor expression and activity | Q40068223 | ||
| The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer | Q40625913 | ||
| The basics of basal transcription by RNA polymerase II. | Q40739619 | ||
| p53 pathway in renal cell carcinoma is repressed by a dominant mechanism. | Q44529532 | ||
| The discovery of first-in-class drugs: origins and evolution. | Q48070614 | ||
| Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer | Q48084125 | ||
| Endometrial Cancer Risk Is Associated with Variants of the Mismatch Repair Genes MLH1 and MSH2 | Q57617807 | ||
| Cell-kill kinetics of several S-phase-specific drugs | Q69578992 | ||
| A 45-year follow-up of kindred 107 and the search for BRCA2 | Q70929979 | ||
| Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells | Q77932887 | ||
| P433 | issue | 3 | |
| P921 | main subject | DNA damage | Q5205747 |
| P304 | page(s) | 455-470 | |
| P577 | publication date | 2015-12-22 | |
| P1433 | published in | Cell Cycle | Q1254166 |
| P1476 | title | ARTIK-52 induces replication-dependent DNA damage and p53 activation exclusively in cells of prostate and breast cancer origin | |
| P478 | volume | 15 |
| Q37552296 | Aberrant DNA Double-strand Break Repair Threads in Breast Carcinoma: Orchestrating Genomic Insult Survival | cites work | P2860 |
Search more.